Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 29:16:2617-2625.
doi: 10.2147/DMSO.S426956. eCollection 2023.

The Correlation Between C-Peptide and Severity of Peripheral Atherosclerosis in Type 2 Diabetes Mellitus

Maisa A Wahab  1 , Alshaymaa M Alhabibi  2 , Ahmed Khairy Sakr  1 , Mohamed Yahia Zakaria  3 , Ola I Saleh  4 , Inass Hassan Ahmad  5 , Eman Kamel Abdelrahman  6 , Randa Sabour Elshahat Taha  4 , Fayka Karem Abdel Azeem Ahmed  4 , Bothayna Ismail  2 , Lamiaa Hosney Azel  5 , Asmaa S Hassan  2 , Hanaa Mohammed Eid El Sayed  7 , Sammar Ahmed Kasim  7 , Safaa Abdelfattah Elsharkawy  8
Affiliations

The Correlation Between C-Peptide and Severity of Peripheral Atherosclerosis in Type 2 Diabetes Mellitus

Maisa A Wahab et al. Diabetes Metab Syndr Obes. .

Abstract

Background: One of the major issues affecting global health is Diabetes mellitus (DM), not only in terms of the disease itself but also its complications. Macrovascular complications are both common and serious, affecting many patients. This study aimed to assess fasting C-peptide levels and correlate them with the severity of the peripheral arterial disease complicating type 2 DM (T2DM).

Patients and methods: This study included 200 participants who were categorized into two groups: Group I (n=100, patients with T2DM complicated by femoropopliteal arterial atherosclerosis) and Group II (n=100, healthy age- and sex-matched individuals serving as controls). Fasting C-peptide levels were estimated using an immunochemiluminometric assay.

Results: Fasting C-peptide levels were significantly higher in Group I than in the control group. Fasting C-peptide levels were positively correlated with the severity of atherosclerosis. In addition, the receiver operating characteristic (ROC) curve analysis revealed that fasting C-peptide levels served as a specific and sensitive marker for detecting the severity of this disease.

Conclusion: Fasting C-peptide levels can be used as a sensitive and specific indicator of the severity of femoropopliteal arteriosclerosis that complicates T2DM.

Keywords: diabetes mellitus; fasting C-peptide; femoropopliteal arteriosclerosis.

PubMed Disclaimer

Conflict of interest statement

All authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
ROC curve for the discriminative power of fasting C-peptide levels between type 2 diabetes mellitus cases and the control group.
Figure 2
Figure 2
ROC curve for the discriminative power of fasting C-peptide levels between early and late stages of femoropopliteal arteriosclerosis.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Guideline of American Diabetes Association. Standards of medical care in diabetes-2016: summary of revisions. Diabetes Care. 2016;39(1):S4–5. PMID: 26696680. doi:10.2337/dc16-S003 - DOI - PubMed
    1. Hegazi R, El-Gamal M, Abdel-Hady N, Hamdy O. Epidemiology of and risk factors for type 2 diabetes in Egypt. Ann Global Health. 2015;81(6):814–820. PMID: 27108148. doi:10.1016/j.aogh.2015.12.011 - DOI - PubMed
    1. Gerbo RM, Jin CF, Clark K. Diabetes in the workplace: the hazards of hypoglycemia. Curr Diab Rep. 2019;19(11):119. PMID: 31686223. doi:10.1007/s11892-019-1234-2 - DOI - PubMed
    1. Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009;53(5 Suppl):S35–42. PMID: 19179216; PMCID: PMC2663393. doi:10.1016/j.jacc.2008.09.055 - DOI - PMC - PubMed
    1. Basyouni MW, Shabana AM, El Kilani WM. Prevalence of lower extremities peripheral arterial disease among Egyptian ischemic patients attending cardiac rehabilitation unit. Egypt Heart J. 2018;70(4):295–299. PMID: 30591746; PMCID: PMC6303360. doi:10.1016/j.ehj.2018.06.005 - DOI - PMC - PubMed